High-throughput behavioral screen in C. elegans reveals novel Parkinson disease drug candidates
Salman Sohrabi, Danielle E. Mor, Rachel L. Kaletsky, William D. Keyes, Coleen Tara Murphy
The paper identifies four FDA-approved drugs, including metformin, as potential Parkinson's disease therapeutics using a high-throughput behavioral screen in C. elegans.
Communications Biology · Feb 15, 2021Peer-reviewedNeuroscience